Each film coated tablet contains Flupentixol dihydrochloride BP equivalent to 0.5 mg Flupentixol and Melitracen hydrochloride INN equivalent to 10 mg Melitracen.
Leanxit® (Flupentixol + Melitracen) consists of two well known and well proven compounds: Flupentixol- a neuroleptic with anxiolytic and antidepressant properties of its own when given in small doses, and Melitracen- a bipolar thymoleptic with activating properties in low doses. In combination the compounds render a preparation with antidepressant, anxiolytic and activating properties.
Anxiety, Depression, Apathy and related diseases.
Adult: Usually 2 tablets daily (morning and noon). In severe cases the morning dose may be increased to 2 tablets.
Elderly patients: 1 tablet in the morning.
Maintenance dose: Usually 1 tablet in the morning. In case of insomnia or severe restlessness additional treatment with a sedative in the acute phase is recommended.
Leanxit® (Flupentixol + Melitracen) may enhance the response to alcohol, barbiturates and other CNS depressants. Simultaneous administration of MAO-inhibitors may cause hypertensive crises.
If previously the patient has been treated with tranquilizers with sedative effect these should be withdrawn gradually.
Use during pregnancy and lactation:
Leanxit® (Flupentixol + Melitracen) should preferably not be given during pregnancy and lactation.
Store in a cool and dry place protected from light. Keep all medicines out of reach of children.